It is clear there are significant overlaps between the molecular pathways including known genetic risk factors such as APOε4 that lead to cognitive dysfunction following TBI and in neurodegenerative diseases such as AD (Tables 1, 2). This evidence concerns the gene APOE and Alzheimer disease.